Protein levels of TAGLN2 were also examined by immunohistochemistry in an independent cohort of human gliomas (n = 46) and normal brain tissues (n = 5) from Qilu Hospital (Jinan, China). This evidence concerns the gene TAGLN2 and central nervous system cancer.